VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
Australia
2024203948
Filed on 2024-06-11
2024203948
Filed on 2024-06-11
METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION
US Patent 11,918,639
Filed on 2021-10-11
Filed on 2021-10-11
METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION
US Patent 11,173,201
Filed on 2019-10-17
Filed on 2019-10-17
CHIMERIC VECTORS
Taiwan
113123612
Filed on 2024-06-25
113123612
Filed on 2024-06-25
ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION
US Application 18/756,709
Filed on 2024-06-27
Filed on 2024-06-27
NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS
Patent Cooperation Treaty
PCT/US2024/035244
Filed on 2024-06-24
PCT/US2024/035244
Filed on 2024-06-24
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof
Japan
2024-091170
Filed on 2024-06-05
2024-091170
Filed on 2024-06-05
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
US Application 18/758,660
Filed on 2024-06-28
Filed on 2024-06-28
BISPECIFIC ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES
Patent Cooperation Treaty
PCT/US2024/038583
Filed on 2024-07-18
PCT/US2024/038583
Filed on 2024-07-18
Prefusion RSV F Proteins And Their Use
Japan
2024-093392
Filed on 2024-06-10
2024-093392
Filed on 2024-06-10